Medical Pharmacology: Drug Metabolism Practice Questions
Choose the correct answer for each question.
Which one(s) of the following will be appropriately described as (a) prodrug(s)?
Tamoxifen
Losartin
Both
Neither
Mitomycin C, an anticancer prodrug, requires activation by among others, a cytochrome P450 reductase to convert the parent compound into a DNA alkylating drug.
True
False
Mitomycin C exhibits selective killing of hypoxic cancer cells associated with core regions of solid tumors.
True
False
Mitomycin selectivity for hypoxic malignant cells in solid tumor core regions occurs because:
These cells have higher concentrations of cytochrome P450 reductase, which activates mitomycin C.
Under hypoxic conditions, re-oxidation of the reduced,
active mitomycin C metabolite is inhibited.
Both
Neither
Phase I enzymes
Cytochrome P450 enzymes
Flavin containing monooxygenase enzymes
Non-cytochrome P450 enzymes
A & B
B & C
A & C
A, B & C
Cytochrome P450 enzymes:
Hepatic microsomal enzymes
Mitochondrial P450 enzymes
Both
Neither
The cytochrome P450 isoform CYP3A4:
Responsible for most cytochrome P450 activity for anesthetic drugs.
CYP3A4 is involved in metabolism of more than 50% of currently available drugs.
Both
Neither
Example/examples of reactions that may utilize cytochrome P450 enzymes:
Hydrolysis reactions
Conjugation
Both
Neither
Conjugation reactions and drug metabolism:
Involves cytochrome P450 enzymes
When glucuronic acid is added to lipid-soluble drugs, the resultant glucuronide conjugates are more water-soluble
and more readily excreted.
Both
Neither
Ester-hydrolysis of drugs, typically at an ester bond, do not require cytochrome P450 enzyme systems.
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above.
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
Source Material:
Buxton ILO Chapter
2: Pharmcokinetics: The Dynamics of Drug Absorption,
Distribution, Metabolism, and Elimiation in Goodman & Gilman's:
The Pharmacological Basis of Therapeutics, 14e, (Brunton LL H
Knollmann BC, eds) McGraw-Hill Education, 2023.
Gonzalez FJ
Coughtrie M Chapter 5: Drug Metabolism in Goodman & Gilman's:
The Pharmacological Basis of Therapeutics, 14e, (Brunton LL H
Knollmann BC, eds) McGraw-Hill Education, 2023.
Holford NHG Chapter
3: Pharmacokinetics & Pharmacodynamics: Rational Dosing &
the Time Course of Drug Action: in Basic & Clinical
Pharmacology (Katzung BG, Editor; Vanderah TW, Associate
editor) 15e McGraw Hill 2021.
Correia MA Chapter 4
Drug Biotransformation in Basic &
Clinical Pharmacology (Katzung BG, Editor; Vanderah TW, Associate
editor) 15e McGraw Hill 2021.
Baca QJ Golan DE
Pharmacokinetics Chapter 3: Principles of Pharmacology:
The Pathophysiologic Basis of Drug Therapy. (Golan DE, editor-in
chief, Armstrong EJ Armstrong AW, associate editors) 4e Wolters
Kluwer 2017.
Guengerich FP
Chapter 4: Drug Metabolism in
Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. (Golan DE, editor-in
chief, Armstrong EJ Armstrong AW, associate editors) 4e Wolters
Kluwer 2017.
Flood P Shafer SL
Chapter 2 Basic Principles of Pharmacology in Stoelting's
Pharmacology & Physiology in Anesthetic Practice (Glood P
Rathmell JP Urman RD, eds) 6e Wolters Kluwer 2022.
Burchum JR Rosenthal
LD Lehne's Pharmacology for Nursing Care Unit II Chapter 4
Pharmcokinetics 11 e Elsevier 2022.